Huntington's Disease Research

Huntington's disease is a neurodegenerative disease characterized by cognitive decline and motor dysfunction. It is a genetic disorder which results in the production of mutant huntingtin protein (mHtt). This protein aggregates in the cell cytoplasm and nucleus, affecting cellular function.

Huntington's Disease Research Products Targets

Products for Huntington's Disease Research - Page 13

Cat.No. Product Name Information/Activity
BCC3850 Risperidone Risperidone is a serotonin 5-HT2 receptor blocker, P-Glycoprotein inhibitor and potent dopamine D2 receptor antagonist, with Kis of 4.8, 5.9 nM for 5-HT2A and dopamine D2 receptor, respectively.
BCC6790 (+)-UH 232 maleate 1217473-50-1
BCC2072 Ziprasidone hydrochloride monohydrate Ziprasidone hydrochloride monohydrate (CP 88059 hydrochloride monohydrate) is a combined 5-HT (serotonin) and dopamine receptor antagonist which exhibits potent effects of antipsychotic activity.
BCC7838 Zotepine 26615-21-4
BCC6353 PAOPA 114200-31-6
BCC7925 Bicifadine hydrochloride 66504-75-4
BCC6846 3α-Bis-(4-fluorophenyl) methoxytropane hydrochloride 202646-03-5
BCC6753 BTCP maleate 207455-25-2
BCC5943 Cocaine hydrochloride 53-21-4
BCC6845 3-CPMT 14008-79-8